Basit öğe kaydını göster

Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial

dc.contributor.authorReina Gutierez, Lourdes
dc.contributor.authorTuzun, Hasan
dc.contributor.authorSabovic, Miso
dc.contributor.authorSubwongcharoen, Somboom
dc.contributor.authorMaggioli, Arnaud
dc.contributor.authorCarpentier, Patrick
dc.contributor.authorvan Bellen, Bonno
dc.contributor.authorKaretova, Debora
dc.contributor.authorHanafiah, Harunarashid
dc.contributor.authorEnriquez-Vega, Elizabeth
dc.contributor.authorKirienko, Alexander
dc.contributor.authorDzupina, Andrej
dc.date.accessioned2021-03-05T12:36:33Z
dc.date.available2021-03-05T12:36:33Z
dc.date.issued2017
dc.identifier.citationCarpentier P., van Bellen B., Karetova D., Hanafiah H., Enriquez-Vega E., Kirienko A., Dzupina A., Sabovic M., Reina Gutierez L., Subwongcharoen S., et al., "Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial", INTERNATIONAL ANGIOLOGY, cilt.36, ss.402-409, 2017
dc.identifier.issn0392-9590
dc.identifier.otherav_adf72d1e-b218-448a-9915-1a6857b0fb94
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/116072
dc.identifier.urihttps://doi.org/10.23736/s0392-9590.17.03801-9
dc.description.abstractBACKGROUND: Chronic venous disorders (CVD) is estimated to affect 30% to 50% of women and 10% to 30% of men. The most widely prescribed treatment for CVD worldwide is micronized purified flavonoid fraction 500 mg (MPFF). The aim of this clinical trial was to develop a new once daily 1000-mg oral suspension of MPFF.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectPERİFERAL VASKÜLER HASTALIĞI
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleClinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial
dc.typeMakale
dc.relation.journalINTERNATIONAL ANGIOLOGY
dc.contributor.departmentCHU Grenoble Alpes , ,
dc.identifier.volume36
dc.identifier.issue5
dc.identifier.startpage402
dc.identifier.endpage409
dc.contributor.firstauthorID246659


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster